Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2011.215 | A randomized controlled study assessing the role of an ambulatory approach versus the conventional approach in managing moderate to severe obstructive sleep apnoea syndrome | Prof Hui David Shu Cheong |
| 2020.089 | A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment |
Dr. HUI David Shu Cheong 許樹昌 |
| 2020.114 | Assessing the risk of exposure and spread of the SARS-CoV-2 virus in the hospital environment |
Dr. HUI David Shu Cheong 許樹昌 |
| 2020.088 | A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19 |
Dr. HUI David Shu Cheong 許樹昌 |
| 2018.433 | A PHASE III, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BALOXAVIR MARBOXIL IN COMBINATION WITH STANDARD-OF-CARE NEURAMINIDASE INHIBITOR IN HOSPITALIZED PATIENTS WITH SEVERE INFLUENZA |
Prof. HUI David Shu Cheong 許樹昌 |
| 2018.185 | A randomized controlled trial of adjunctive sirolimus and oseltamivir versus oseltamivir alone for treatment of influenza |
Prof. HUI David Shu Cheong 許樹昌 |
| 2019.451 | A 24-week multi-center, double-blind, placebo controlled dose-range finding study to investigate the efficacy and safety of oral QBW251 in COPD patients on triple inhaled therapy (LABA/LAMA/ICS) |
Prof. HUI David Shu Cheong 許樹昌 |
| 2018.250 | Observational study to assess frailty of subjects during ZOSTER-006 and ZOSTER-022 and HZ efficacy, immunogenicity and safety of HZ/su by frailty status. | Prof. HUI David Shu Cheong |
| 2020.122 | Effect of long term Clarithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis in Asian populations | Prof. HUI David Shu Cheong |
| 2018.613 | A randomized, double blind, placebo controlled trial of intravenous N-acetylcysteine and oseltamivir versus intravenous 5% dextrose and oseltamivir alone in adults hospitalized with influenza complicated by lower respiratory tract infection |
Prof. HUI David Shu Cheong 許樹昌 |
| 2019.392 | A phase III, randomized, observer-blind, placebo controlled, multicenter clinical trial to assess Herpes Zoster recurrence and the reactogenicity, safety and immunogenicity of GSK Biologicals’ Herpes Zoster vaccine (HZ/su) when administered intramuscularly on a 0 and 2 month schedule to adults ≥ 50 years of age with a prior episode of Herpes Zoster. |
Prof. HUI David Shu Cheong 許樹昌 |
| 2019.634 | Screening for lung cancer in subjects with family history of lung cancer. |
Prof. HUI David Shu Cheong 許樹昌教授 |
| 2020.203 | The safety of high flow nasal cannula and noninvasive ventilation for treatment of patients with COVID-19 complicated by respiratory failure |
Prof. HUI David Shu Cheong 許樹昌教授 |
| 2020.229 | Long-term longitudinal comparisons of health and immunity status in convalescent COVID-19 and vaccinated cohorts in Hong Kong |
Prof. HUI David Shu Cheong 許樹昌 |
| 2019.510 | PREPARE Study: PRevalence of the Eosinophilic Phenotype Among SeveRE Asthma Patients in AstraZeneca International Region. A Multinational, Cross-Sectional, Multicenter Study |
Prof. HUI David Shu Cheong 許樹昌教授 |
| 2020.220 | Tropism and pathogenesis of SARS-CoV-2 in human macrophages |
Prof. HUI David Shu Cheong 許樹昌 |
| 2026.399 | A Randomized, Double-Blind, 2×2 Factorial Trial of Baloxavir Plus Oseltamivir Versus Oseltamivir Plus Placebo and of Azithromycin Versus Placebo in Adults Hospitalized with Influenza | Prof. Hui David Shu Cheong |
| 2026.687 | An open-label, roll-over study evaluating the long-term safety and efficacy of an oral dose of verducatib q.d. in patients with bronchiectasis (AIRTIVITY®-ON) | Prof. Hui David Shu Cheong |
| 2023.628 | Long-term longitudinal comparisons of health status and immune responses in elderly cohorts with seasonal influenza vaccine in Hong Kong | Prof. HUI David Shu Cheong |
| 2025.022 | BRISOTE: A Multicentre, Randomised, Double-Blind, Parallel Group, Active-Controlled, Phase 3b Study to Evaluate the Efficacy and Safety of Benralizumab 30 mg SC in Eosinophilic Asthma Patients Uncontrolled on Medium-Dose Inhaled Corticosteroid Plus Long-acting β2-Agonist | Prof. HUI David Shu Cheong |
| 2024.628 | A Phase 2b, Randomised, Double-Blind, Placebo-Controlled Dose Range-Finding Study to Assess Efficacy and Safety of Multiple Dose Levels of Inhaled AZD8630 Given Once Daily for 12 Weeks in Adults with Uncontrolled Asthma at Risk of Exacerbations (LEVANTE) | Prof. HUI David Shu Cheong |
| 2024.240 | A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma | Prof. HUI David Shu Cheong |
| 2025.364 | A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY) | Prof. HUI David Shu Cheong |
| 2024.207 | A study to evaluate the consistency of oscillometry and spirometry test results in patients with confirmed or suspected asthma or COPD |
Prof. HUI David Shu Cheong 許樹昌 |
| 2024.428 | The disease burden of RSV infection in Hong Kong | Prof. HUI David Shu Cheong |
| 2024.481 | SA-BioPercept study: A survey study on biologics initiation from the perspective of moderate-tosevere asthma patients | Prof. HUI David Shu Cheong |
| 2025.318 | A Phase III, randomised, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of BI 1291583 2.5 mg administered once daily for up to 76 weeks in patients with bronchiectasis (The AIRTIVITY™ Study) | Prof. HUI David Shu Cheong |
| 2008.131 | A Multi-center Study of the Therapeutic Role of Continuous Positive Airway Pressure Therapy on Ischemic Stroke Survivors with Obstructive Sleep Apnoea Syndrome | Prof Hui David Shu-Cheong |
| 2011.257 | A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy | Dr. HUI Edwin Pun |
| 2007.101 | Immune Responses in Nasopharyngeal Carcinoma | Dr. HUI Edwin Pun |
| 2020.337 | Development and validation of HA electronic Frailty Index (HA-eFI) |
Dr. HUI Elsie 許鷗思 |
| 2013.423 | Evaluation of Quality of Care : Risk Assessment and Management Programme - Hypertension, Hospital Authority | Dr. HUI Eric Ming Tung |
| 2016.055 | In-depth study of the cost-effectiveness of the Risk Assessment and Management Programme for Hypertension (RAMP-HT) for patients with uncontrolled hypertension in primary care in Hong Kong |
Dr. HUI Eric Ming Tung 許明通 |
| 2009.627 | Association between Physical Activity Knowledge, Physical Activity Behavior, and Age in Hong Kong Chinese Adults with Type 2 Diabetes | Dr. Hui Grace Pui Sze |
| 2013.132 | Glycogen Storage Disease Type 1 in Hong Kong: diagnosis, clinical course and outcome | Dr Hui Joannie |
| 2015.098 | Rare Disease Registry Program | Dr. HUI Joannie |
| 2016.567 | International Network on Neurotransmitter related Disorder (iNTD) Registry |
Dr. HUI Joannie 許鍾妮 |
| 2011.319 | Knowledge, Attitude and Practice of Chronic Disease Patient on Counterfelt Drugs buying in Hong Kong | Mr Hui Ka Chun |
| 2017.456 | A Retrospective Evaluation of the use of Crisis Packs in Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease in a local hospital |
Mr. HUI Kei Shing 許基誠 |
| 2019.616 | Economic evaluation on breastfeeding promotion in Hong Kong |
Dr. HUI Lai Ling 許麗玲 |
| 2019.492 | A study on the view of Hong Kong parents on secondary use of dried blood spots in newborn screening program - implications on evidence-based policies |
Dr. HUI Lai Ling 許麗玲 |
| 2025.080 | Comparison of suicidal fall and accidental fall patient characteristics in fall from height patients | Dr. HUI Lok Hin |
| 2017.294 | Retrospective analysis of Candida parapsilosis complex fungaemia. |
Dr. HUI Mamie 許明媚 |
| 2025.776 | TEMPORARY LOOP ILEOSTOMY VS. TRANSVERSE COLOSTOMY: Impact on Renal Function After Total Mesorectal Excision (TME) Post Neoadjuvant Chemoradiotherapy (NACRT) | Dr. Hui Matthew Ming Hon |
| 2012.203 | The validation of the screening programme for diabetic retinopathy | Dr Hui Ming Tung Eric |
| 2014.223 | The Association between Black Carbon/Ground-level Ozone and Acute Respiratory Effects in Healthy Young Adult Cyclists- A Crossover Study in Hong Kong | Miss HUI Nga Ting |
| 2018.508 | Development and validation of a risk model integrating post-radiotherapy plasma Epstein-Bar virus DNA and TNM stage for stratification of nasopharyngeal cancer to adjuvant therapy |
Dr. HUI Pun 許斌 |
| 2019.205 | The Effects of a Combined Acute and Chronic Aerobic Exercise Program on Autonomic and Cognitive Functions with Acute Psychological Stress |
Prof. HUI Sai Chuen 許世全 |
| 2025.143 | Chest X-ray Artificial Intelligence Assistance for Radiologist - A Proof of Concept | Prof. HUI Sai Kam |
| 2010.572 | A Phase III international, randomized, double-blind, double-dummy study to evaluate the efficacy and safety of 300 mg or 600 mg of intravenous zanamivir twice daily compared to 75 mg of oral oseltamivir twice daily in the treatment of hospitalized adults and adolescents with influenza | Prof. Hui Shu Cheong David |
Page 108 of 289.